111 (YI) Asset Writedowns and Impairment (2019)
111 (YI) posted Asset Writedowns and Impairment of $3.1 million for Q4 2019, up 90.44% sequentially from $1.6 million in Q1 2019.
111 (YI) Asset Writedowns and Impairment (2019) Analysis & Trends
111 has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $3.1 million in Q4 2019.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $3.1 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $4.8 million (changed N/A YoY) and the FY2025 annual result came in at $258000.0, down 51.59% from the prior year.
- Asset Writedowns and Impairment grew to $3.1 million in Q4 2019 per YI's latest filing, from $1.6 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $3.1 million in Q4 2019 and troughed at $1.6 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 3.12 Mn |
| Dec 31, 2019 | 3.12 Mn |
| Mar 31, 2019 | 1.64 Mn |
| Mar 31, 2019 | 1.64 Mn |